Home » Stocks » NPTX » Company

Neuropathix, Inc (NPTX)

Stock Price: $0.1299 USD -0.0001 (-0.08%)
Updated Jun 23, 2021 3:09 PM EDT - Market closed
Neuropathix, Inc
Founded 2010
Industry Biotechnology
Sector Healthcare
Employees 7

Contact Details

Address:Pennsylvania Biotechnology Center
Doylestown, PA 18902
United States
Phone 858 883 2642

Stock Information

Ticker Symbol NPTX
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 1615999

Company Description

Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary cannabinoid product platform.

It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy.

The company was formerly known as Kannalife, Inc. and changed its name to Neuropathix, Inc. in November 2020. Neuropathix, Inc. was founded in 2010 and is based in Doylestown, Pennsylvania.

Key Executives

Dean PetkanasChairman and Chief Executive Officer
Thomas Evangelos KikisFounder, Chief Communications Officer and Director
Mark CorraoChief Financial Officer
Dr. William A. Kinney Ph.D.Chief Scientific Officer
Mark McDonnell Ph.D.Chief Chemist